Bicycle Therapeutics Ipo Nasdaq

Bcyc a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide bicycle product platform today announced the pricing of its initial public offering in the united states of 4 333 333 american depositary shares adss representing 4 333 333.

Bicycle therapeutics ipo nasdaq. The company reported 0 67 earnings per share eps for the quarter missing the zacks consensus estimate of 0 48 by 0 19. Bicycle therapeutics plc american depositary shares bcyc after hours stock quotes nasdaq offers after hours quotes and extended trading activity data for us and global markets. The company had revenue of 1 57 million for the quarter compared to the consensus estimate of 2 11 million. Meanwhile the bicycle therapeutics ipo raised 60 6 million.

Bicycle therapeutics had a negative return. Bicycle therapeutics bcyc saw a big move last session as its shares jumped nearly 9 on the day amid huge volumes. Bicycle priced its offering of approximately 4 4 million shares at 14 apiece which was the low end of its targeted price range. Adrs aktie wird unter der isin us0887861088 an den börsen frankfurt münchen stuttgart berlin nasdaq bats tradegate lang schwarz und baader bank.

Bicycle therapeutics limited nasdaq bcyc announced its quarterly earnings results on wednesday august 5th. Bicycle therapeutics plc american depositary shares bcyc stock quotes nasdaq offers stock quotes market activity data for us and global markets. Cambridge england boston business wire may 22 2019 bicycle therapeutics plc nasdaq. Bicycle therapeutics is a clinical stage biopharmaceutical company developing a novel class of medicines called bicycles for diseases that are underserved by existing therapeutics.

Bicycles are fully synthetic short peptides constrained to form two loops that stabilize their structural geometry. 24 2020 at 8 37 a m. See us on twitter social media bicycle tx september 2 2020 today we announced that the first patient has been dosed in a phase ii trial of bicycle toxin conjugate bt1718 s. Bicycle therapeutics will issue 4 33 million.